overview

• Identify new HCV patients in Japan by leveraging GPs as HCV advocators
• Educate key leadership MDs (from 5 regions in Japan) about how to turn GPs into HCV advocators, by providing the understanding of GPs so that the key leadership MDs effectively educate GPs in their own region
• Develop an effective program in which key leadership MDs can educate GPs in their own region; material should include key data regarding the understandings of GPs, which will be obtained through the survey to GPs

This activity is supported by educational grants from AbbVie, Bristol-Myers Squibb, and Gilead Sciences.